Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD

Both fibroblast growth factor 23 (FGF-23) and asymmetric dimethylarginine (ADMA) are associated with progression of CKD. We tested the hypothesis that ADMA and FGF23 are interactive factors for CKD progression in a cohort of 758 patients with CKD in Southern Europe (mean eGFR±SD, 36±13 ml/min per 1....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Am Soc Nephrol
Glavni autori: Tripepi, Giovanni, Kollerits, Barbara, Leonardis, Daniela, Yilmaz, Mahamut Ilker, Postorino, Maurizio, Fliser, Danilo, Mallamaci, Francesca, Kronenberg, Florian, Zoccali, Carmine
Format: Artigo
Jezik:Inglês
Izdano: American Society of Nephrology 2015
Teme:
Clinical Epidemiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4378102/
https://ncbi.nlm.nih.gov/pubmed/25150156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2013121355
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items